Scilex Holding Company
Scilex Holding Company (SCLX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Scilex Holding Company (SCLX), covering cash flow, earnings, and balance sheets.
Scilex Holding Company (SCLX) Income Statement & Financial Overview
Analyze Scilex Holding Company’s SCLX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.004M | $14.90M | $14.44M | $16.37M |
| Cost of Revenue | $1.38M | $4.69M | $3.77M | $4.39M |
| Gross Profit | $3.62M | $10.21M | $10.67M | $11.98M |
| Gross Profit Ratio | $0.72 | $0.69 | $0.74 | $0.73 |
| R&D Expenses | $2.46M | $2.18M | $2.35M | $2.004M |
| SG&A Expenses | $28.06M | $35.41M | $29.73M | $24.60M |
| Operating Expenses | $31.52M | $38.59M | $30.59M | $27.60M |
| Total Costs & Expenses | $32.90M | $41.75M | $34.35M | $31.99M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.48M | $285000.00 | $576000.00 | $571000.00 |
| Depreciation & Amortization | $0.00 | $1.004M | $1.005M | $1.005M |
| EBITDA | -$27.90M | -$5.17M | -$2.81M | -$36.006M |
| EBITDA Ratio | -$5.58 | -$0.35 | -$0.19 | -$2.20 |
| Operating Income | -$27.90M | -$28.38M | -$19.92M | -$15.62M |
| Operating Income Ratio | -$5.58 | -$1.90 | -$1.38 | -$0.95 |
| Other Income/Expenses (Net) | $1.82M | $21.92M | $15.53M | -$21.96M |
| Income Before Tax | -$26.08M | -$6.46M | -$4.39M | -$37.58M |
| Income Before Tax Ratio | -$5.21 | -$0.43 | -$0.30 | -$2.30 |
| Income Tax Expense | $0.00 | -$1000.00 | $0.00 | $0.00 |
| Net Income | -$26.08M | -$6.46M | -$4.39M | -$37.58M |
| Net Income Ratio | -$5.21 | -$0.43 | -$0.30 | -$2.30 |
| EPS | -$2.26 | -$0.05 | -$0.03 | -$0.31 |
| Diluted EPS | -$2.26 | -$0.05 | -$0.03 | -$0.31 |
| Weighted Avg Shares Outstanding | $11.56M | $6.95M | $3.63M | $3.43M |
| Weighted Avg Shares Outstanding (Diluted) | $11.56M | $6.95M | $3.63M | $3.43M |
Financial performance has remained strong, with revenue growing from $16.37M in Q2 2024 to $5.004M in Q1 2025. Gross profit continued to perform well, with margins at 72% in the latest quarter. Operating income reached -$27.90M in Q1 2025, holding a steady -558% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$27.90M. Net income dropped to -$26.08M, keeping EPS at -$2.26. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan